Brief: Peptonic Medical Q4 Operating Loss Widens To SEK 11.5 Mln

Peptonic Medical AB

27/02/2020 08:34

Feb 27 (Reuters) - Peptonic Medical AB  PMED.TE :
    * YEAR END REPORT
    * Q4 NET SALES OF PRODUCTS SEK 394,000 (263,000)
    * BOARD OF DIRECTORS PROPOSES THAT NO DIVIDEND IS PAID FOR
FISCAL
YEAR 2019
    * Q4 OPERATING LOSS SEK 11.5 MILLION VERSUS LOSS SEK 4.6
MILLION
YEAR AGO

Source text for Eikon:  ID:nWkr5nM9cD 
Further company coverage:  PMED.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))